NovaBay Pharmaceuticals (NBY) had the lowest return in 2015 by a US stock in the Pharmaceuticals Industry, returning -86.6%.
| ASSET | YEAR | % RETURN |
|---|---|---|
NovaBay Pharmaceuticals (NBY) | 2015 | -86.56% |
Relmada Therapeutics (RLMD) | 2015 | -84.13% |
Traws Pharma (TRAW) | 2015 | -70.74% |
SIGA Technologies (SIGA) | 2015 | -70.63% |
Akari Therapeutics (AKTX) | 2015 | -69.79% |
TNF Pharmaceuticals (TNFA) | 2015 | -69.67% |
Ocular Therapeutix (OCUL) | 2015 | -60.14% |
Pulmatrix (PULM) | 2015 | -52.14% |
China Pharma (CPHI) | 2015 | -49.39% |
Evoke Pharma (EVOK) | 2015 | -45.45% |
Talphera (TLPH) | 2015 | -43.13% |
Scynexis (SCYX) | 2015 | -37.71% |
Omeros (OMER) | 2015 | -37.31% |
Hepion Pharmaceuticals (HEPA) | 2015 | -30.63% |
Marinus Pharmaceuticals (MRNS) | 2015 | -29.91% |
Bausch Health Companies (BHC) | 2015 | -29.4% |
Avadel Pharmaceuticals (AVDL) | 2015 | -28.72% |
Innoviva (INVA) | 2015 | -22.99% |
Sonoma Pharmaceuticals (SNOA) | 2015 | -21.77% |
ANI Pharmaceuticals (ANIP) | 2015 | -20.27% |
Jazz Pharmaceuticals (JAZZ) | 2015 | -15.3% |
Cassava Sciences (SAVA) | 2015 | -14.22% |
Pacira BioSciences (PCRX) | 2015 | -14.13% |
Cumberland Pharmaceuticals (CPIX) | 2015 | -12.77% |
Perrigo (PRGO) | 2015 | -12.56% |
